Literature DB >> 10383407

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

M Febbraio1, N A Abumrad, D P Hajjar, K Sharma, W Cheng, S F Pearce, R L Silverstein.   

Abstract

A null mutation in the scavenger receptor gene CD36 was created in mice by targeted homologous recombination. These mice produced no detectable CD36 protein, were viable, and bred normally. A significant decrease in binding and uptake of oxidized low density lipoprotein was observed in peritoneal macrophages of null mice as compared with those from control mice. CD36 null animals had a significant increase in fasting levels of cholesterol, nonesterified free fatty acids, and triacylglycerol. The increase in cholesterol was mainly within the high density lipoprotein fraction, while the increase in triacylglycerol was within the very low density lipoprotein fraction. Null animals had lower fasting serum glucose levels when compared with wild type controls. Uptake of 3H-labeled oleate was significantly reduced in adipocytes from null mice. However, the decrease was limited to the low ratios of fatty acid:bovine serum albumin, suggesting that CD36 was necessary for the high affinity component of the uptake process. The data provide evidence for a functional role for CD36 in lipoprotein/fatty acid metabolism that was previously underappreciated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383407     DOI: 10.1074/jbc.274.27.19055

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  271 in total

1.  Scavenging new insights into atherogenesis.

Authors:  M P de Winther; M H Hofker
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Plasmodium yoelii sporozoites infect CD36-deficient mice.

Authors:  Photini Sinnis; Maria Febbraio
Journal:  Exp Parasitol       Date:  2002-01       Impact factor: 2.011

Review 3.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.

Authors:  Tahar Hajri; Xiao Xia Han; Arend Bonen; Nada A Abumrad
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

5.  The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.

Authors:  Eric Malaud; Delphine Hourton; Louise Marie Giroux; Ewa Ninio; Robin Buckland; John L McGregor
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

Review 6.  Fat cell metabolism: insulin, fatty acids, and renin.

Authors:  L A Cassis
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 7.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 8.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

9.  TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.

Authors:  Sudipta Biswas; Alejandro Zimman; Detao Gao; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2017-08-03       Impact factor: 17.367

10.  oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.

Authors:  Jingyi Ren; Wenying Jin; Hong Chen
Journal:  Mol Cell Biochem       Date:  2010-05-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.